explore -WSS

explore

author：explore 2025-09-30 20:35:30 - browse：9

Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Apple Watch's A

WSS

Biden's order seeks to regulate AI risk without stifling innovation

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Readout LOUD podcast: What to know about H5N1 bird flu

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Eli Lilly to pay $200M for Beam’s stake in gene

Traditional Chinese medicine benefits explored in new JAMA study

entertainment

explore

focus

After affirmative action ruling, medical educators look to 'holistic review'

How to improve immunocompromised access to mAb treatments

Sports medicine is finally prioritizing gender equality

Medicare says breakthrough device reimbursement rule to come by summer

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Researchers on aging grapple with how to calculate biological age

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

CDC wastewater surveillance dashboard to track bird flu hotspots

Medicare details structure of new drug price negotiation program

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

entertainment

Dairy farmers resist CDC push for PPE against bird flu virus

CDC recommends rationing of RSV shot due to shortages

Steward Health Care files for bankruptcy

Testing for cancer recurrence creates a new limbo for patients

Apple Watch's A

Biden's order seeks to regulate AI risk without stifling innovation

knowledge

entertainment

hotspot

entertainment